GSK to invest Rs. 8.64 billion in pharmaceutical manufacturing in India

Monday, 18 November 2013 06:34 administrator
Print

GSK LogoThe announcement means creation of additional local employment opportunities.

 

Mumbai. A new Rs. 8.64 billion factory creating 250 jobs in India was recently announced by healthcare company GlaxoSmithKline (GSK) as part of its continued commitment to ensuring access to medicines for people in the country.

As per GSK. the location of the new factory is yet to be finalised, but the lead site is in Bangalore. When complete the new factory will make pharmaceutical products for the Indian market at a rate of up eight billion tablets and one billion capsules a year. The facility, expected to be operational by 2017, will also include a warehouse, site infrastructure and utilities to support the manufacturing and packing of the medicines.

GSK will partner with local design and construction companies to build a state of the art manufacturing facility which is expected to benefit from leading edge technologies including continuous manufacturing and automated systems.

The company has aleady invested Rs. 10.17 billion in India over the last decade.

GSK Chief Executive Officer Sir Andrew Witty said, "GSK is a long-standing investor in India and we fully support the Government in their efforts to increase access to affordable medicines and to improve healthcare. This new facility will substantially increase the capacity of our manufacturing base and enable us to bring more medicines to the people of India."